HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ibuprofen Better Than Paracetamol At Reducing Fever In Children And Just As Safe – Study

Executive Summary

A meta-analysis finds moderate-quality evidence that compared with paracetamol (also known as acetaminophen), ibuprofen is more effective at reducing fever in children under two years old, and despite concerns, has a similar safety profile.

You may also be interested in...



France Moving Paracetamol and NSAIDs Behind Pharmacy Counter From January

Fears over patient safety will see common OTC drugs including paracetamol moved behind the counter in France from January 2020.

Australia Rejects Hair-Loss Switch, Up-Schedules Modified-Release Paracetamol

Australia has rejected an application to switch an oral hair-loss treatment, while also up-scheduling modified release paracetamol over safety concerns.

Real-World Data One Of Five Areas For Improvement For EU Digital Self-Care Regulation

The AESGP in a new position paper calls for a flexible regulatory framework to unlock the "tremendous opportunity" of digital innovation in self-care. 

Topics

UsernamePublicRestriction

Register

RS150665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel